BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 27836865)

  • 21. DHX15 is involved in SUGP1-mediated RNA missplicing by mutant SF3B1 in cancer.
    Zhang J; Huang J; Xu K; Xing P; Huang Y; Liu Z; Tong L; Manley JL
    Proc Natl Acad Sci U S A; 2022 Dec; 119(49):e2216712119. PubMed ID: 36459648
    [No Abstract]   [Full Text] [Related]  

  • 22. Defects in spliceosomal machinery: a new pathway of leukaemogenesis.
    Maciejewski JP; Padgett RA
    Br J Haematol; 2012 Jul; 158(2):165-173. PubMed ID: 22594801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms and Regulation of Alternative Pre-mRNA Splicing.
    Lee Y; Rio DC
    Annu Rev Biochem; 2015; 84():291-323. PubMed ID: 25784052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Splicing Factor Mutations in Cancer.
    Bejar R
    Adv Exp Med Biol; 2016; 907():215-28. PubMed ID: 27256388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcript specificity in yeast pre-mRNA splicing revealed by mutations in core spliceosomal components.
    Pleiss JA; Whitworth GB; Bergkessel M; Guthrie C
    PLoS Biol; 2007 Apr; 5(4):e90. PubMed ID: 17388687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. snRNP proteins in health and disease.
    Krausová M; Staněk D
    Semin Cell Dev Biol; 2018 Jul; 79():92-102. PubMed ID: 29037818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The NineTeen Complex (NTC) and NTC-associated proteins as targets for spliceosomal ATPase action during pre-mRNA splicing.
    de Almeida RA; O'Keefe RT
    RNA Biol; 2015; 12(2):109-14. PubMed ID: 25654271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple protein-protein interactions converging on the Prp38 protein during activation of the human spliceosome.
    Schütze T; Ulrich AK; Apelt L; Will CL; Bartlick N; Seeger M; Weber G; Lührmann R; Stelzl U; Wahl MC
    RNA; 2016 Feb; 22(2):265-77. PubMed ID: 26673105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The exosome controls alternative splicing by mediating the gene expression and assembly of the spliceosome complex.
    Zhang L; Wan Y; Huang G; Wang D; Yu X; Huang G; Guo J
    Sci Rep; 2015 Aug; 5():13403. PubMed ID: 26306464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications.
    Pellagatti A; Boultwood J
    Adv Biol Regul; 2017 Jan; 63():59-70. PubMed ID: 27639445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insights into the Involvement of Spliceosomal Mutations in Myelodysplastic Disorders from Analysis of SACY-1/DDX41 in
    Tsukamoto T; Gearhart MD; Kim S; Mekonnen G; Spike CA; Greenstein D
    Genetics; 2020 Apr; 214(4):869-893. PubMed ID: 32060018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigating the Molecular Mechanism of H3B-8800: A Splicing Modulator Inducing Preferential Lethality in Spliceosome-Mutant Cancers.
    Spinello A; Borišek J; Malcovati L; Magistrato A
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spliceosomal gene mutations in myelodysplasia: molecular links to clonal abnormalities of hematopoiesis.
    Inoue D; Bradley RK; Abdel-Wahab O
    Genes Dev; 2016 May; 30(9):989-1001. PubMed ID: 27151974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-mRNA splicing in disease and therapeutics.
    Singh RK; Cooper TA
    Trends Mol Med; 2012 Aug; 18(8):472-82. PubMed ID: 22819011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic approaches to treat human spliceosomal diseases.
    DeNicola AB; Tang Y
    Curr Opin Biotechnol; 2019 Dec; 60():72-81. PubMed ID: 30772756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic protein-protein interaction wiring of the human spliceosome.
    Hegele A; Kamburov A; Grossmann A; Sourlis C; Wowro S; Weimann M; Will CL; Pena V; Lührmann R; Stelzl U
    Mol Cell; 2012 Feb; 45(4):567-80. PubMed ID: 22365833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human immunodeficiency virus type 1 Vpr interacts with spliceosomal protein SAP145 to mediate cellular pre-mRNA splicing inhibition.
    Hashizume C; Kuramitsu M; Zhang X; Kurosawa T; Kamata M; Aida Y
    Microbes Infect; 2007 Apr; 9(4):490-7. PubMed ID: 17347016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The evolutionary conservation of the splicing apparatus between fission yeast and man.
    Wentz-Hunter K; Potashkin J
    Nucleic Acids Symp Ser; 1995; (33):226-8. PubMed ID: 8643378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The splicing factor Prp17 interacts with the U2, U5 and U6 snRNPs and associates with the spliceosome pre- and post-catalysis.
    Sapra AK; Khandelia P; Vijayraghavan U
    Biochem J; 2008 Dec; 416(3):365-74. PubMed ID: 18691155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutational landscape of RNA-binding proteins in human cancers.
    Neelamraju Y; Gonzalez-Perez A; Bhat-Nakshatri P; Nakshatri H; Janga SC
    RNA Biol; 2018 Jan; 15(1):115-129. PubMed ID: 29023197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.